Crenae Therapeutics Revenue

Biotechnology Research • Anthem, Arizona, United States • 1-10 Employees

Crenae Therapeutics revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at Crenae Therapeutics

Mark Olsen

Chief Executive Officer and Founder

Company overview

Headquarters	39925 N. Pride Dr., Phoenix, Arizona 85086, US
NAICS	541714
Keywords	Biotechnology, Small Molecule, Antibody, Antimetastatic, Anticancer
Founded	2017
Employees	1-10

About Crenae Therapeutics

Crenae Therapeutics is focused on the development of anti-ASPH therapeutics for the treatment of metastatic cancer. ASPH inhibitors are non-toxic, orally bioavailable, Notch pathway modulators without dose limiting GI toxicity like previous Notch therapeutics. A robust IP portfolio, including small molecules, antibody diagnostics and therapeutics, and backup chemotypes provides a strong IP foundation for developing anti-ASPH therapeutics. Target cancers include veterinary, human orphan cancers such as cholangiocarcinoma and fibrolamellar hepatocellular carcinoma, and large market cancers including lung, hepatocellular carcinoma, breast, pancreatic, gastric and colon cancers.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Crenae Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Crenae Therapeutics has never raised funding before.

Frequently asked questions

Crenae Therapeutics is located in Anthem, Arizona, US.

Crenae Therapeutics generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

Crenae Therapeutics has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Crenae Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Crenae Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Crenae Therapeutics

Mark Olsen

Chief Executive Officer and Founder

4.8

40,000 users